IL1-TRAP, Rilonacept, in Systemic Sclerosis
Clinical trial NCT01538719 · COMPLETED
Trial details
- NCT number
- NCT01538719
- Sponsor
- Boston University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2017-01-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.